Practical Genetic and Biologic Therapeutic Considerations in Vascular Anomalies
- 1 December 2019
- journal article
- research article
- Published by Elsevier in Techniques in Vascular and Interventional Radiology
- Vol. 22 (4) , 100629
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- 2014 Revised Classification of Vascular Lesions from the International Society for the Study of Vascular Anomalies: Radiologic-Pathologic UpdateRadioGraphics, 2016
- Efficacy and Safety of Sirolimus in the Treatment of Complicated Vascular AnomaliesPediatrics, 2016
- Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular AnomaliesPediatrics, 2015
- Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CAThe Journal of Pediatrics, 2015
- PIK3CA‐related overgrowth spectrum (PROS): Diagnostic and testing eligibility criteria, differential diagnosis, and evaluationAmerican Journal of Medical Genetics Part A, 2014
- Kaposiform Lymphangiomatosis: A Distinct Aggressive Lymphatic AnomalyThe Journal of Pediatrics, 2014
- Somatic Mosaic Activating Mutations in PIK3CA Cause CLOVES SyndromeThe American Journal of Human Genetics, 2012
- Sirolimus for the treatment of complicated vascular anomalies in childrenPediatric Blood & Cancer, 2011
- From germline towards somatic mutations in the pathophysiology of vascular anomaliesHuman Molecular Genetics, 2009
- Somatic mutations in angiopoietin receptor gene TEK cause solitary and multiple sporadic venous malformationsNature Genetics, 2008